209 related articles for article (PubMed ID: 35285349)
1. Edible plant-derived nanotherapeutics and nanocarriers: recent progress and future directions.
Chen N; Sun J; Zhu Z; Cribbs AP; Xiao B
Expert Opin Drug Deliv; 2022 Apr; 19(4):409-419. PubMed ID: 35285349
[TBL] [Abstract][Full Text] [Related]
2. Plant-derived exosomal nanoparticles: potential therapeutic for inflammatory bowel disease.
Li DF; Tang Q; Yang MF; Xu HM; Zhu MZ; Zhang Y; Tian CM; Nie YQ; Wang JY; Liang YJ; Wang LS; Yao J
Nanoscale Adv; 2023 Jul; 5(14):3575-3588. PubMed ID: 37441251
[TBL] [Abstract][Full Text] [Related]
3. Plant-derived exosome-like nanoparticles: A concise review on its extraction methods, content, bioactivities, and potential as functional food ingredient.
Suharta S; Barlian A; Hidajah AC; Notobroto HB; Ana ID; Indariani S; Wungu TDK; Wijaya CH
J Food Sci; 2021 Jul; 86(7):2838-2850. PubMed ID: 34151426
[TBL] [Abstract][Full Text] [Related]
4. Isolation of plant-derived exosome-like nanoparticles (PDENs) from Solanum nigrum L. berries and Their Effect on interleukin-6 expression as a potential anti-inflammatory agent.
Emmanuela N; Muhammad DR; Iriawati ; Wijaya CH; Ratnadewi YMD; Takemori H; Ana ID; Yuniati R; Handayani W; Wungu TDK; Tabata Y; Barlian A
PLoS One; 2024; 19(1):e0296259. PubMed ID: 38175845
[TBL] [Abstract][Full Text] [Related]
5. Plant Exosome-like Nanovesicles: Emerging Therapeutics and Drug Delivery Nanoplatforms.
Dad HA; Gu TW; Zhu AQ; Huang LQ; Peng LH
Mol Ther; 2021 Jan; 29(1):13-31. PubMed ID: 33278566
[TBL] [Abstract][Full Text] [Related]
6. Leukocyte-mediated Delivery of Nanotherapeutics in Inflammatory and Tumor Sites.
Dong X; Chu D; Wang Z
Theranostics; 2017; 7(3):751-763. PubMed ID: 28255364
[TBL] [Abstract][Full Text] [Related]
7. Nanoparticle-Mediated Drug Delivery Systems For The Treatment Of IBD: Current Perspectives.
Yang C; Merlin D
Int J Nanomedicine; 2019; 14():8875-8889. PubMed ID: 32009785
[TBL] [Abstract][Full Text] [Related]
8. Plant-Derived Exosome-like Nanoparticles for Biomedical Applications and Regenerative Therapy.
Sarasati A; Syahruddin MH; Nuryanti A; Ana ID; Barlian A; Wijaya CH; Ratnadewi D; Wungu TDK; Takemori H
Biomedicines; 2023 Mar; 11(4):. PubMed ID: 37189671
[TBL] [Abstract][Full Text] [Related]
9. Nanotherapeutics: An insight into healthcare and multi-dimensional applications in medical sector of the modern world.
Prasad M; Lambe UP; Brar B; Shah I; J M; Ranjan K; Rao R; Kumar S; Mahant S; Khurana SK; Iqbal HMN; Dhama K; Misri J; Prasad G
Biomed Pharmacother; 2018 Jan; 97():1521-1537. PubMed ID: 29793315
[TBL] [Abstract][Full Text] [Related]
10. Orally delivered targeted nanotherapeutics for the treatment of colorectal cancer.
Zhang X; Song H; Canup BSB; Xiao B
Expert Opin Drug Deliv; 2020 Jun; 17(6):781-790. PubMed ID: 32237921
[TBL] [Abstract][Full Text] [Related]
11. Multifunctional and stimuli-responsive nanocarriers for targeted therapeutic delivery.
Majumder J; Minko T
Expert Opin Drug Deliv; 2021 Feb; 18(2):205-227. PubMed ID: 32969740
[TBL] [Abstract][Full Text] [Related]
12. Cell-free synthesis of connexin 43-integrated exosome-mimetic nanoparticles for siRNA delivery.
Lu M; Zhao X; Xing H; Liu H; Lang L; Yang T; Xun Z; Wang D; Ding P
Acta Biomater; 2019 Sep; 96():517-536. PubMed ID: 31284098
[TBL] [Abstract][Full Text] [Related]
13. Improved Targeting of Cancers with Nanotherapeutics.
Foster C; Watson A; Kaplinsky J; Kamaly N
Methods Mol Biol; 2017; 1530():13-37. PubMed ID: 28150194
[TBL] [Abstract][Full Text] [Related]
14. Nanoparticle-mediated gene therapy as a novel strategy for the treatment of retinoblastoma.
Mandal M; Banerjee I; Mandal M
Colloids Surf B Biointerfaces; 2022 Dec; 220():112899. PubMed ID: 36252537
[TBL] [Abstract][Full Text] [Related]
15. Recent progressions in biomedical and pharmaceutical applications of chitosan nanoparticles: A comprehensive review.
Khalaf EM; Abood NA; Atta RZ; RamÃrez-Coronel AA; Alazragi R; Parra RMR; Abed OH; Abosaooda M; Jalil AT; Mustafa YF; Narmani A; Farhood B
Int J Biol Macromol; 2023 Mar; 231():123354. PubMed ID: 36681228
[TBL] [Abstract][Full Text] [Related]
16. Nanoparticle Drug Delivery Can Reduce the Hepatotoxicity of Therapeutic Cargo.
Yang F; Medik Y; Li L; Tian X; Fu D; Brouwer KLR; Wagner K; Sun B; Sendi H; Mi Y; Wang AZ
Small; 2020 Feb; 16(7):e1906360. PubMed ID: 31972070
[TBL] [Abstract][Full Text] [Related]
17. Edible plant extracellular vesicles: An emerging tool for bioactives delivery.
Fan SJ; Chen JY; Tang CH; Zhao QY; Zhang JM; Qin YC
Front Immunol; 2022; 13():1028418. PubMed ID: 36569896
[TBL] [Abstract][Full Text] [Related]
18. Small interfering RNA-based nanotherapeutics for treating skin-related diseases.
Chang YT; Huang TH; Alalaiwe A; Hwang E; Fang JY
Expert Opin Drug Deliv; 2023 Jun; 20(6):757-772. PubMed ID: 37088710
[TBL] [Abstract][Full Text] [Related]
19. Nanotherapeutics in oral and parenteral drug delivery: Key learnings and future outlooks as we think small.
Tyagi P; Subramony JA
J Control Release; 2018 Feb; 272():159-168. PubMed ID: 29355619
[TBL] [Abstract][Full Text] [Related]
20. Purposing plant-derived exosomes-like nanovesicles for drug delivery: patents and literature review.
Orefice NS; Di Raimo R; Mizzoni D; Logozzi M; Fais S
Expert Opin Ther Pat; 2023 Feb; 33(2):89-100. PubMed ID: 36947052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
